LOVE Pharma Co. (CSE:LUV) (FSE:G1Q0) updated details on the proposed Microdoz Therapy acquisition, whereby Microdoz has engaged exclusively with researchers at Johns Hopkins University, to conduct a landmark study into the potential of psilocybin assisted treatment of cannabis use disorder.
The company noted that it is looking forward to working with the university and research experts on the study and, ultimately, licensing and commercializing the intellectual property developed by the landmark study.
